RIBC1

Across TCGA pan-cancer cohorts, RIBC1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RIBC1 data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RIBC1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated RIBC1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD, UCEC, and GBM are the cancer types where RIBC1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.475	0.940	.006	19	view →
UCEC	OS	Median	All	1.000	0.684	.024	2	view →
GBM	OS	Median	All	0.368	0.660	.034	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RIBC1–LUAD (DFS)

Open the LUAD breakdown →